Sterneck Capital Management, LLC Amgen Inc Transaction History

Sterneck Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $173,104 - $206,136	-800 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $187,720 - $208,760	800 New	800 $203,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $240,877 - $271,557	-1,300 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$169.43 - $198.0 $220,259 - $257,400	1,300 New	1,300 $222,000

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sterneck Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sterneck Capital Management, LLC with notifications on news.